Landec’s Lifecore Subsidiary Shifting Shipments From Our Second Fiscal Quarter to Our Third Fiscal Quarter

MENLO PARK, Calif., Oct. 16, 2012 (GLOBE NEWSWIRE) — Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets innovative and patented products for food and biomedical applications, today announced that certain customers of its wholly-owned biomaterials subsidiary, Lifecore Biomedical, Inc., have requested that shipments originally planned to be shipped in November be shipped in December, which will result in revenues and profits planned for the second quarter being recognized in the third quarter. Therefore, approximately $3.0 million of gross profit is being shifted from Landec’s second fiscal quarter to Landec’s third fiscal quarter.

Read entire release…